基于细胞的疗法用于治疗类风湿性关节炎
Maryam Zare Moghaddam1, Mohammad Javad Mousavi2, Somayeh Ghotloo3,4
1Department of Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Immunity, inflammation and disease
|November 29, 2023
概括
基于细胞的疗法,使用干细胞和非干细胞,通过调节免疫反应,显示出治疗诸如类风湿性关节炎之类的自身免疫疾病的前景. 本次审查评估了它们的有效性,安全性和最佳使用.
科学领域:
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
- 细胞疗法细胞疗法
背景情况:
- 自身免疫性疾病,如类风湿性关节炎,源于免疫系统的自我耐受性崩.
- 基于细胞的疗法,利用干细胞和非干细胞,正在成为潜在的治疗方法.
- 这些细胞具有独特的特性,包括分化和免疫调节作用.
研究的目的:
- 审查各种基于细胞的疗法对自身免疫性疾病的疗效.
- 评估干细胞 (介质细胞,造血细胞,胚胎细胞,羊水膜细胞) 和非干细胞 (调节性T细胞,CAR-T细胞,宽容性树突细胞).
- 讨论安全性,免疫学变化,细胞源选择和治疗限制.
主要方法:
- 对基于细胞的治疗方法的当前文献进行系统审查.
- 对介质干细胞,造血干细胞,胚胎干细胞和人类羊水膜细胞的疗效数据的评估.
- 在自身免疫性疾病模型和临床研究中对调节性T细胞,仿真抗原受体T细胞和宽容性树突细胞的评估.
主要成果:
- 基于细胞的疗法在临床前和临床环境中显示出显著的免疫调节潜力.
- 特定的细胞类型表现出不同程度的疗效和安全性.
- 需要进一步的研究来优化细胞选择,调节和长期结果.
结论:
- 基于细胞的疗法为控制自身免疫性疾病提供了一个有希望的途径.
- 仔细考虑细胞类型,起源和治疗方案对于成功应用至关重要.
- 目前正在进行的研究旨在完善这些治疗方法,解决安全性和疗效方面的问题.
相关概念视频
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:19Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
143
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
143
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K